Invasive Aspergillosis Superinfection Possible in Symptomatic COVID-19
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
Infectious Disease
Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease
New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.
Influenza Vaccine for Older Adults Granted Fast Track Status
The Food and Drug Administration has granted Fast Track designation to NanoFlu (Novavax) for seasonal influenza vaccination in adults ≥65 years.
Oseltamivir Reduces Recovery Time for Influenza-Like Illness in European Study
Oseltamivir may reduce recovery time for primary care patients with influenza-like illness, especially for older, sicker patients with comorbidities.
Community Acquired Pneumonia Guidelines
Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.
Influenza Vaccine Comparisons (2019−2020 Season)
Compare and contrast influenza vaccines currently available for the 2018-2019 flu season including indicated ages, allergies, and how supplied.
Influenza Vaccine Recommendations: Egg Allergies
Influenza vaccine recommendations for individuals who report an allergy to eggs.
Influenza Vaccine Dosing Algorithm: 6 Months-8 Years
Influenza vaccine dosing algorithm for children 6 months to 8 years of age.
The Fine Art of Administering a Tuberculin Skin Test
When administered correctly, the Mantoux test can be an invaluable tool for the detection of tuberculosis.
Antiviral Agents Compared for Treatment of Influenza
In otherwise healthy patients, influenza treatment with baloxavir marboxil was found to be comparable, and on some efficacy measures, superior to neuraminidase inhibitors.
-
Loading...
-
Loading...
